[1]
Cieślikowski, W.A. et al. 2021. Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells. EXCLI Journal. 20, (Nov. 2021), 1585–1596. DOI:https://doi.org/10.17179/excli2021-3980.